US 11702473
Site-specific antibody-drug conjugates
granted A61KA61K47/68035A61K47/6867
Quick answer
US patent 11702473 (Site-specific antibody-drug conjugates) held by ADC THERAPEUTICS SA expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADC THERAPEUTICS SA
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K47/68035, A61K47/6867, A61P, A61P35/02